Location: New York, NY
CIK: 0001831942 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $2.048B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 3,525,000 | $332M | 16.2% | $30.24 | — | COM | N5749R100 |
| NUVL | NUVALENT INC | 1,400,000 | $121M | 5.9% | $67.32 | +17.4% | COM | 670703107 |
| XENE | XENON PHARMACEUTICALS INC | 2,700,000 | $108M | 5.3% | $30.82 | +14.3% | COM | 98420N105 |
| COGT | COGENT BIOSCIENCES INC | 7,250,000 | $104M | 5.1% | $10.67 | +11.1% | COM | 19240Q201 |
| ELVN | ENLIVEN THERAPEUTICS INC | 4,692,809 | $96.06M | 4.7% | $19.08 | +5.6% | COM | 29337E102 |
| AGIO | AGIOS PHARMACEUTICALS INC | 2,338,287 | $93.86M | 4.6% | $33.00 | +14.0% | COM | 00847X104 |
| ALKS | ALKERMES PLC | 3,096,754 | $92.9M | 4.5% | $26.85 | +5.0% | SHS | G01767105 |
| SLNO | SOLENO THERAPEUTICS INC | 1,350,000 | $91.26M | 4.5% | $58.91 | +25.8% | COM | 834203309 |
| RLAY | RELAY THERAPEUTICS INC | 17,000,000 | $88.74M | 4.3% | $3.15 | +20.9% | COM | 75943R102 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 3,028,335 | $78.34M | 3.8% | $22.13 | +4.7% | COM NEW | 15117B202 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,850,000 | $69.11M | 3.4% | $15.31 | — | SPONSORED ADS | 152309100 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,200,000 | $69.06M | 3.4% | $15.97 | +13.0% | COM | 92790C104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,025,000 | $68.09M | 3.3% | $47.99 | +18.4% | COM | 74366E102 |
| PHVS | PHARVARIS N V | 2,418,476 | $60.34M | 2.9% | $22.98 | -3.5% | COM | N69605108 |
| — | CIDARA THERAPEUTICS INC | 585,000 | $56.02M | 2.7% | $48.71 | — | COM NEW | 171757206 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 4,075,478 | $55.39M | 2.7% | $9.41 | 0.0% | COM | 03237H101 |
| TYRA | TYRA BIOSCIENCES INC | 3,375,000 | $47.22M | 2.3% | $10.62 | +7.3% | COM | 90240B106 |
| TERN | TERNS PHARMACEUTICALS INC | 5,700,000 | $42.81M | 2.1% | $6.39 | 0.0% | COM | 880881107 |
| KYMR | KYMERA THERAPEUTICS INC | 750,000 | $42.45M | 2.1% | $34.43 | +31.0% | COM | 501575104 |
| — | MIND MEDICINE MINDMED INC | 3,225,000 | $38.02M | 1.9% | $8.32 | — | COM NEW | 60255C885 |
| NRIX | NURIX THERAPEUTICS INC | 3,780,055 | $34.93M | 1.7% | $21.29 | -51.2% | COM | 67080M103 |
| ORKA | ORUKA THERAPEUTICS INC | 1,753,054 | $33.71M | 1.6% | $30.70 | -51.7% | COM | 687604108 |
| SYRE | SPYRE THERAPEUTICS INC | 1,988,084 | $33.32M | 1.6% | $14.79 | +10.3% | COM NEW | 00773J202 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 500,000 | $30.33M | 1.5% | $35.19 | +10.3% | COM NEW | 10919W405 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 1,000,000 | $25.6M | 1.2% | $21.94 | 0.0% | COM NEW | 045396207 |
| CTMX | CYTOMX THERAPEUTICS INC | 7,692,300 | $24.54M | 1.2% | $1.61 | +39.7% | COM | 23284F105 |
| LBRX | LB PHARMACEUTICALS INC | 1,500,000 | $23.68M | 1.2% | $15.87 | 0.0% | COM SHS | 50180M108 |
| TNGX | TANGO THERAPEUTICS INC | 1,500,000 | $12.6M | 0.6% | $2.47 | +173.7% | COM | 87583X109 |
| APGE | APOGEE THERAPEUTICS INC | 290,000 | $11.52M | 0.6% | $25.01 | +52.6% | COM | 03770N101 |
| PEPG | PEPGEN INC | 2,357,319 | $10.89M | 0.5% | $1.61 | 0.0% | COM | 713317105 |
| ENTA | ENANTA PHARMACEUTICALS INC | 800,000 | $9.576M | 0.5% | $7.99 | 0.0% | COM | 29251M106 |
| SABS | SAB BIOTHERAPEUTICS INC | 4,401,500 | $8.847M | 0.4% | $2.26 | 0.0% | COM NEW | 78397T202 |
| IKT | INHIBIKASE THERAPEUTICS INC | 5,397,488 | $8.744M | 0.4% | $2.49 | -30.6% | COM NEW | 45719W205 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7.92M | 0.4% | $10.07 | +5.1% | CL A ORD SHS | G70077105 |
| AVTX | AVALO THERAPEUTICS INC | 483,000 | $6.139M | 0.3% | $10.53 | -18.3% | COM NEW | 05338F306 |
| VTGN | VISTAGEN THERAPEUTICS INC | 1,575,000 | $5.591M | 0.3% | $4.44 | -32.7% | COM | 92840H400 |
| CBIO | CRESCENT BIOPHARMA INC. | 450,829 | $5.36M | 0.3% | $21.15 | -37.3% | COM | G2545C104 |